Sleepwalking and sleep-related eating associated with atypical antipsychotic medications: Case series and systematic review of literature.

Psychiatry and Behavioral Health Institute, Department of Sleep Medicine, Allegheny Health Network, Pittsburgh, PA, United States. Electronic address: Amit.CHOPRA@ahn.org. Department of Psychiatry, Griffin Memorial Hospital, Norman, OK, United States. Department of Psychiatry, Dartmouth Hitchcock Medical Center, Lebanon, NH, United States. Electronic address: Nisha.P.Baliga@hitchcock.org. Psychiatry and Behavioral Health Institute, Allegheny Health Network, Pittsburgh, PA, United States. Electronic address: anoop.narahari@ahn.org. Department of Sleep Medicine, CentraCare, MN, United States. Electronic address: Piyush.Das@centracare.com.

General hospital psychiatry. 2020;:74-81
Full text from:

Other resources

Abstract

BACKGROUND Sleep walking (SW) is a parasomnia behavior characterized by repetitious occurrence of ambulation during a partial arousal from non-rapid eye movement (NREM) sleep. Sleep-related eating (SRE) is one of the complex sleep behaviors that may accompany SW. Emerging evidence suggests that NREM parasomnias can be associated with atypical antipsychotic medication use. METHODS We present a case series (n = 5) and a systematic review of the literature of cases of SW, with or without SRE (n = 23), associated with atypical antipsychotic use. RESULTS Twenty-eight cases of SW, with and without SRE, with a mean age of 44.8 years (S.D. = 15.04) and a male predominance (75%; n = 21) were identified. Quetiapine was the most commonly implicated medication with SW and SRE (n = 14). Remission from SW/SRE was noted in all cases with measures including antipsychotic dosage reduction, discontinuation of medication, switching to an alternate medication, and use of continuous positive airway pressure (CPAP) for comorbid obstructive sleep apnea (OSA) treatment. CONCLUSIONS Sleep walking (SW), with or without sleep related eating (SRE), can be a rare but reversible side effect associated with use of atypical antipsychotics. More research is warranted to elucidate the mechanisms underlying SW and SRE associated with atypical antipsychotic use.